Coronary disease & ACS

Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease

Circ Cardiovasc ImagingPublished Secondary analysis of the 18F-flurpiridaz phase III trial

Primary result · RFR per vesselResult — go to the resultOdds ratio 3.08 95% CI 1.49–6.38

Authors' conclusion

RFR provides complementary diagnostic information beyond existing positron emission tomography parameters and may help refine the diagnosis of obstructive CAD in patients with reduced flows.

Study context

Population
Patients in the phase III 18F-flurpiridaz PET trial with available myocardial blood flow (MBF) quantification (71% male; 56% with established coronary artery disease (CAD))from 755 trial participants
Participants
231 patients
Comparison
PET relative flow reserve (RFR) added to existing PET parameters for diagnosis of obstructive CAD
Primary endpoint
Incremental diagnostic value of PET-derived RFR for obstructive CAD (≥70% stenosis on quantitative invasive coronary angiography)
Methodological detailspost hoc diagnostic accuracy study, multicentre, No patients had 3-vessel CAD
  • Post hoc diagnostic accuracy study
  • Multicentre
  • No patients had 3-vessel CAD

Primary result

RFR per vessel

Odds ratio

3.08

95% CI 1.49–6.38

P = 0.002

By group

Obstructive CAD

0.55

Nonobstructive CAD

0.80

RFR
OR 3.08 (95% CI 1.49–6.38); P = 0.002

Per vessel, as printed

As reported in the abstract

Further findings

Discrimination of obstructive CAD with addition of RFR (AUC)

Addition of RFR did not significantly improve discrimination (AUC 0.806 vs 0.822)
P = 0.11

Reclassification of vessels with addition of RFR

Net reclassification index
0.93
Obstructive CAD net reclassification index
0.44
Nonobstructive CAD net reclassification index
0.49
  • P<0.0001

Vessels with reduced stress MBF (sMBF) without obstructive CAD on invasive coronary angiography (per-vessel)

Vessels with reduced sMBF with no obstructive CAD
82%

Original publication

Utility of 18 F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease. Circ Cardiovasc Imaging. Published 9 October 2025. doi:10.1161/circimaging.125.018323

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.